These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39330662)

  • 1. The Remarkable and Selective In Vitro Cytotoxicity of Synthesized Bola-Amphiphilic Nanovesicles on Etoposide-Sensitive and -Resistant Neuroblastoma Cells.
    Alfei S; Giannoni P; Signorello MG; Torazza C; Zuccari G; Athanassopoulos CM; Domenicotti C; Marengo B
    Nanomaterials (Basel); 2024 Sep; 14(18):. PubMed ID: 39330662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strongly ROS-Correlated, Time-Dependent, and Selective Antiproliferative Effects of Synthesized Nano Vesicles on BRAF Mutant Melanoma Cells and Their Hyaluronic Acid-Based Hydrogel Formulation.
    Alfei S; Zuccari G; Athanassopoulos CM; Domenicotti C; Marengo B
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesized
    Alfei S; Zuccari G; Bacchetti F; Torazza C; Milanese M; Siciliano C; Athanassopoulos CM; Piatti G; Schito AM
    Nanomaterials (Basel); 2024 Aug; 14(16):. PubMed ID: 39195389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazo-Pyrazole-Loaded Palmitic Acid and Polystyrene-Based Nanoparticles: Synthesis, Characterization and Antiproliferative Activity on Chemo-Resistant Human Neuroblastoma Cells.
    Valenti GE; Marengo B; Milanese M; Zuccari G; Brullo C; Domenicotti C; Alfei S
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide Dendrimers with Non-Symmetric Bola Structure Exert Long Term Effect on Glioblastoma and Neuroblastoma Cell Lines.
    Sowińska M; Szeliga M; Morawiak M; Ziemińska E; Zabłocka B; Urbańczyk-Lipkowska Z
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33804286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Polystyrene-Based Cationic Nanomaterials with Pro-Oxidant Cytotoxic Activity on Etoposide-Resistant Neuroblastoma Cells.
    Alfei S; Marengo B; Valenti GE; Domenicotti C
    Nanomaterials (Basel); 2021 Apr; 11(4):. PubMed ID: 33920180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple approaches to repurposing drugs for neuroblastoma.
    Rank L; Puhl AC; Havener TM; Anderson E; Foil DH; Zorn KM; Monakhova N; Riabova O; Hickey AJ; Makarov V; Ekins S
    Bioorg Med Chem; 2022 Nov; 73():117043. PubMed ID: 36208544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.
    Tanos R; Karmali D; Nalluri S; Goldsmith KC
    BMC Cancer; 2016 Feb; 16():97. PubMed ID: 26874859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazole-Enriched Cationic Nanoparticles Induced Early- and Late-Stage Apoptosis in Neuroblastoma Cells at Sub-Micromolar Concentrations.
    Zuccari G; Zorzoli A; Marimpietri D; Brullo C; Alfei S
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
    Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of lactobionic acid based bola-amphiphiles and its application as nano-carrier for curcumin delivery to cancer cell cultures in-vitro.
    Habib SM; Jawad-Ur-Rehman ; Maharjan R; Kanwal T; Althagafi II; Saifullah S; Ullah S; Simjee SU; Shah MR
    Int J Pharm; 2020 Nov; 590():119897. PubMed ID: 32971176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WP744 is a novel anthracycline with enhanced activity against neuroblastoma.
    Inge TH; Harris NL; Wu J; Azizkhan RG; Priebe W
    J Surg Res; 2004 Oct; 121(2):187-96. PubMed ID: 15501458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
    Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
    Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation.
    Marengo B; Monti P; Miele M; Menichini P; Ottaggio L; Foggetti G; Pulliero A; Izzotti A; Speciale A; Garbarino O; Traverso N; Fronza G; Domenicotti C
    Sci Rep; 2018 Sep; 8(1):13762. PubMed ID: 30213983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.
    Pezzolo A; Parodi F; Marimpietri D; Raffaghello L; Cocco C; Pistorio A; Mosconi M; Gambini C; Cilli M; Deaglio S; Malavasi F; Pistoia V
    Cell Res; 2011 Oct; 21(10):1470-86. PubMed ID: 21403679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.
    Colla R; Izzotti A; De Ciucis C; Fenoglio D; Ravera S; Speciale A; Ricciarelli R; Furfaro AL; Pulliero A; Passalacqua M; Traverso N; Pronzato MA; Domenicotti C; Marengo B
    Oncotarget; 2016 Oct; 7(43):70715-70737. PubMed ID: 27683112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
    Li M; Wang J; Guo P; Jin L; Tan X; Zhang Z; Zhanghuang C; Mi T; Liu J; Wang Z; Wu X; Wei G; He D
    Biomater Adv; 2022 Nov; 142():213161. PubMed ID: 36308859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression.
    Jin W; Zhang Y; Zhao Z; Gao M
    Theranostics; 2024; 14(9):3439-3469. PubMed ID: 38948053
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.
    Gheeya JS; Chen QR; Benjamin CD; Cheuk AT; Tsang P; Chung JY; Metaferia BB; Badgett TC; Johansson P; Wei JS; Hewitt SM; Khan J
    Cancer Biol Ther; 2009 Dec; 8(24):2386-95. PubMed ID: 19946221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.